Patheon is sharing a series of papers on, targeting the early phase pharmaceutical development process.

Development of a pharmaceutical product needs to be fast and flexible to cope with the unique challenges of NCEs and the need for rapid proof of concept.

This series of papers covers tactics to successfully manage poorly soluble drugs and high-potency compounds, as well as strategies to deliver early phase solid and sterile products.

Patheon is a leading provider of contract development and commercial manufacturing (CDMO) services to the global pharmaceutical industry for a full array of solid and sterile dosage forms.

Patheon encompasses the combined CMO capabilities and pharmaceutical product development services (PDS), as well as the biosolutions and biologics (BIO) business. The team of early development experts at Patheon have generated these papers from their expertise derived from working on thousands of projects.

To find out more, click here.